Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Synapse (New York, N.Y.)|December 18, 2007
Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptorsChih-Liang Chin, James R Pauly, Bruce W Surber, et al.Pharmacology, Biochemistry, and Behavior|May 17, 2005
Dopamine D2, but not D4, receptor agonists are emetogenic in ferretsMark A Osinski, Marie E Uchic, Terese Seifert, et al.Clinical and Experimental Pharmacology & Physiology|February 1, 2006
Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agentsLee C Preusser, Ryan M Fryer, Armin Gerhardt, et al.The Journal of Pharmacology and Experimental Therapeutics|May 30, 2009
Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamsterAndrew J King, Jason A Segreti, Kelly J Larson, et al.Journal of Magnetic Resonance Imaging : JMRI|September 3, 2002
Evaluation of tissue perfusion in a rat model of hind-limb muscle ischemia using dynamic contrast-enhanced magnetic resonance imagingYanping Luo, Kurt M Mohning, Vincent P Hradil, et al.Cancer Gene Therapy|June 13, 2022
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibitionChandra C Ghosh, Kara R Heatherton, Kyle P O' Connell, et al.Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.Cancer Chemotherapy and Pharmacology|June 3, 2004
Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic studyJason A Segreti, James S Polakowski, Kristin A Koch, et al.Surgery|June 30, 2023
Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer modelBenedict A Capacio, Jayanth S Shankara Narayanan, Diego A Vicente, et al.Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.Pageof 7